Skip to main content

Point72 Asset Management, L.P.

Position in SLN — Silence Therapeutics plc

CIK 1603466 STAMFORD, CT

Position in SLN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$630,876
-$62,669 QoQ
Shares Held
119,711
+4.9% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $630,876 119,711
2025-12-31 $693,545 114,070
2025-03-31 $45,210 16,032
2024-12-31 $4,355,728 633,100
2024-09-30 $8,504,604 467,800
2024-06-30 $2,783,500 146,500
2024-03-31 $177,120 8,200
2023-06-30 $476,850 86,700
2023-03-31 $2,166,664 349,462
2022-12-31 $5,651,070 370,562
2022-09-30 $5,528,030 550,875
2022-06-30 $2,962,500 250,000
2022-03-31 $4,750,000 250,000
2021-12-31 $5,972,500 250,000